PICKING OUT GOURDS TO DECORATE
We have considered
PARP inhibitors (PARPi) several times. There
are three currently approved for treatment of ovarian cancer: drug names Lynparza, Zejula, Rubraca. They are not a cure but rather a means to
prolong PFS (progression-free survival) without recourse to more chemotherapy,
which may seriously impact quality of life.
PARPi works best in cases where the BRCA gene is mutated, but may be of
some benefit for other OVCA patients.
This article contains much useful information which, with luck, you will
never need. Read it anyway.
Note that it
would be very beneficial to know one’s BRCA status. Any blanket health care system that we may
eventually adopt ought to cover BRCA testing for every female. Tell your favorite local legislator.
No comments:
Post a Comment